Glyburide Tablet
Product Images NDC 68788-8508

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 68788-8508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glyburide Tablets Usp 5mg (Cf21c8c0 7247 4d5b 97f8 Ae4016144642 00)

Label for Glyburide Tablets USP 5 mg, oral tablets manufactured by Cadila Pharmaceuticals Limited. The label includes storage instructions, a caution about alcohol use, and warnings, with bilingual directions in English and Spanish. The label also displays the Preferred Pharmaceuticals, Inc. logo and placeholders for lot number, expiration date, and insurance information.*

FDA Label Image

Glyburide-fig-1 (Glyburide Fig 1)

Chemical structure of Glyburide, showing its molecular composition including aromatic rings, chlorine, methoxy group, amide bonds, sulfonamide group, and a cyclohexyl ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.